Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 6
Submit an article Journal homepage
604
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Tyrosine kinase inhibitor therapy treatment and discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States: a clinical practice perspective

Ellen K. RitchieDepartment of Hematology/Oncology, Weill Cornell Medical College of Cornell University, New York, NY, USA; Correspondence[email protected]
View further author information
,
Dominick Latremouille-ViauAnalysis Group, Inc, Montreal, Canada; View further author information
,
Annie GuerinAnalysis Group, Inc, Montreal, Canada; View further author information
,
Irina PivnevaAnalysis Group, Inc, Montreal, Canada; View further author information
,
Karen HabuckyNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA; View further author information
,
Briana NdifeNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA; View further author information
,
George J. JosephNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA; View further author information
&
Ehab L. AtallahMedical College of Wisconsin, Milwaukee, WI, USAView further author information
 show all
Pages 1476-1484 | Received 14 Aug 2018, Accepted 13 Oct 2018, Published online: 22 Jan 2019

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ehab L. Atallah, Islam Sadek, Rodrigo Maegawa, Xiting Cao, Dominick Latremouille-Viau, Irina Pivneva, Carmine Rossi, Annie Guerin & Vamsi Kota. (2021) Tyrosine kinase inhibitor therapy discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States after clinical practice guideline updates. Leukemia & Lymphoma 62:7, pages 1730-1739.
Read now

Articles from other publishers (3)

Nicole Held & Ehab L. Atallah. (2023) Real-world Management of CML: Outcomes and Treatment Patterns. Current Hematologic Malignancy Reports.
Crossref
Emilie Cayssials, Jose Torregrosa‐Diaz, Pilar Gallego‐Hernanz, Florence Tartarin, Thomas Systchenko, Natacha Maillard, Déborah Desmier, Antoine Machet, Emmanuel Fleck, Anne Corby, Carine Motard, Guillaume Denis, André Herbelin, Jean‐Marc Gombert, Lydia Roy, Stéphanie Ragot, Xavier Leleu, François Guilhot & Jean‐Claude Chomel. (2020) Low‐dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment‐free remission in chronic myeloid leukemia patients: Results of a retrospective study. Cancer 126:15, pages 3438-3447.
Crossref
Stephen E. Langabeer, Rehman Faryal, Michael O’Dwyer & Sorcha Ní Loingsigh. (2020) Patient-Initiated Discontinuation of Tyrosine Kinase Inhibitor for Chronic Myeloid Leukemia. Case Reports in Hematology 2020, pages 1-4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.